Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-23-014883

Options or other derivatives

  • Director acquired 36,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Harwin Peter Evan Director 2023-06-07 Grant or award · Stock Option (Right to Buy) +36,700 36,700 D
Loading xslF345X04/doc4.xml…